Literature DB >> 28818883

Determinants and outcomes of prolonged anxiety and depression in idiopathic pulmonary fibrosis.

Ian N Glaspole1,2, Alice L Watson3, Heather Allan4, Sally Chapman5, Wendy A Cooper6,7,8, Tamera J Corte9,10, Samantha Ellis11, Christopher Grainge12,13, Nicole Goh14,15, Peter Hopkins16, Gregory Keir17, Sacha Macansh4, Annabelle Mahar6,7, Yuben Moodley18, Paul N Reynolds5, Christopher J Ryerson19, E Haydn Walters20, Christopher J Zappala21, Anne E Holland2,3,22.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28818883     DOI: 10.1183/13993003.00168-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  11 in total

Review 1.  International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results.

Authors:  C Herrmann
Journal:  J Psychosom Res       Date:  1997-01       Impact factor: 3.006

2.  Australian Idiopathic Pulmonary Fibrosis Registry: vital lessons from a national prospective collaborative project.

Authors:  Yuben Moodley; Nicole Goh; Ian Glaspole; Sacha Macansh; E Haydn Walters; Sally Chapman; Peter Hopkins; Paul N Reynolds; Christopher Zappala; Wendy Cooper; Annabelle Mahar; Samantha Ellis; Samuel McCormack; William Darbishire; Richard Wood-Baker; Tamera J Corte
Journal:  Respirology       Date:  2014-08-14       Impact factor: 6.424

3.  Depression and functional status are strongly associated with dyspnea in interstitial lung disease.

Authors:  Christopher J Ryerson; Jane Berkeley; Virginia L Carrieri-Kohlman; Steven Z Pantilat; C Seth Landefeld; Harold R Collard
Journal:  Chest       Date:  2010-08-05       Impact factor: 9.410

4.  Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease.

Authors:  Anne E Holland; Julio F Fiore; Emily C Bell; Nicole Goh; Glen Westall; Karen Symons; Leona Dowman; Ian Glaspole
Journal:  Respirology       Date:  2014-08-12       Impact factor: 6.424

5.  Validation of a new dyspnea measure: the UCSD Shortness of Breath Questionnaire. University of California, San Diego.

Authors:  E G Eakin; P M Resnikoff; L M Prewitt; A L Ries; R M Kaplan
Journal:  Chest       Date:  1998-03       Impact factor: 9.410

6.  Depression is a common and chronic comorbidity in patients with interstitial lung disease.

Authors:  Christopher J Ryerson; Patricia A Arean; Jane Berkeley; Virginia L Carrieri-Kohlman; Steven Z Pantilat; C Seth Landefeld; Harold R Collard
Journal:  Respirology       Date:  2012-04       Impact factor: 6.424

Review 7.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review.

Authors:  Ingvar Bjelland; Alv A Dahl; Tone Tangen Haug; Dag Neckelmann
Journal:  J Psychosom Res       Date:  2002-02       Impact factor: 3.006

8.  The hospital anxiety and depression scale.

Authors:  A S Zigmond; R P Snaith
Journal:  Acta Psychiatr Scand       Date:  1983-06       Impact factor: 6.392

9.  Validation of the Cough Quality-of-Life Questionnaire in patients with idiopathic pulmonary fibrosis.

Authors:  Noah Lechtzin; Marisa E Hilliard; Maureen R Horton
Journal:  Chest       Date:  2013-06       Impact factor: 9.410

Review 10.  Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis.

Authors:  Amy L Olson; Kevin K Brown; Jeffrey J Swigris
Journal:  Patient Relat Outcome Meas       Date:  2016-05-17
View more
  7 in total

1.  Multi-dimensional Assessment of IPF Across a Wide Range of Disease Severity.

Authors:  Hana Serajeddini; Paola Rogliani; Marco Mura
Journal:  Lung       Date:  2018-08-27       Impact factor: 2.584

2.  The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis.

Authors:  Andreas Guenther; Ekaterina Krauss; Silke Tello; Jasmin Wagner; Bettina Paul; Stefan Kuhn; Olga Maurer; Sabine Heinemann; Ulrich Costabel; María Asunción Nieto Barbero; Veronika Müller; Philippe Bonniaud; Carlo Vancheri; Athol Wells; Martina Vasakova; Alberto Pesci; Matteo Sofia; Walter Klepetko; Werner Seeger; Fotios Drakopanagiotakis; Bruno Crestani
Journal:  Respir Res       Date:  2018-07-28

3.  Supportive care of patients with fibrosing interstitial lung disease: answering a great clinical need.

Authors:  Amanda T Goodwin; Gauri Saini
Journal:  Breathe (Sheff)       Date:  2020-09

Review 4.  Idiopathic pulmonary fibrosis beyond the lung: understanding disease mechanisms to improve diagnosis and management.

Authors:  Fabrizio Luppi; Meena Kalluri; Paola Faverio; Michael Kreuter; Giovanni Ferrara
Journal:  Respir Res       Date:  2021-04-17

5.  Nutritional status and quality of life in interstitial lung disease: a prospective cohort study.

Authors:  Alisar A Kanjrawi; Lara Mathers; Susanne Webster; Tamera J Corte; Sharon Carey
Journal:  BMC Pulm Med       Date:  2021-02-05       Impact factor: 3.317

Review 6.  Cough in Idiopathic Pulmonary Fibrosis.

Authors:  Jennifer Mann; Nicole S L Goh; Anne E Holland; Yet Hong Khor
Journal:  Front Rehabil Sci       Date:  2021-10-18

Review 7.  Comorbidities, Complications and Non-Pharmacologic Treatment in Idiopathic Pulmonary Fibrosis.

Authors:  Paloma Millan-Billi; Candela Serra; Ana Alonso Leon; Diego Castillo
Journal:  Med Sci (Basel)       Date:  2018-07-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.